Epidemic Mumps in Russia: Epidemic Situation, Key Challenges and Solutions
https://doi.org/10.31631/2073-3046-2019-18-6-75-80
Abstract
Relevance.In the second decade of the 21st century, mumps still attracted the attention of scientists and practitioners around the world for their epidemiological, social and economic importance. A ubiquitous but uneven spread of mumps infection has been established in various regions of the world: in Europe, the Eastern Mediterranean, Southeast Asia, Africa, America, and the Western Pacific.
Aim. Present the current state of the incidence of mumps in the Russian Federation.
Conclusions. The current epidemic situation of mumps in the Russian Federation is characterized by a predominance in the age structure of the incidence of adolescents and young working age people and determines the need to develop and introduce in medical activity a standard definition of the clinical case of mumps for correct verification of the diagnosis with subsequent laboratory confirmation. The emergence of the phenomenon of «growing up» of mumps and the registration of periodic outbreaks in the long-term practice of vaccination dictates the need to improve further vaccination prevention tactics with an emphasis on the adult population as part of the implementation of the National preventive vaccination calendar.
About the Authors
V. V. Semerikov
Perm State Pharmaceutical Academy
Russian Federation
Russian Federation
Vadislav V. Semerikov – Dr. Sci. (Med.), professor of the Department of Microbiology
Polevaya str. 2, Perm, 614990.
+7 (919)479-71-08, +7 (342) 236-46-15
N. V. Yuminova
Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Russian Federation
Nadezhda V. Yuminova – Doctor of Biological Sciences, Professor, Deputy Director for Science, Head of the Laboratory for Children’s Viral Infections
+7 (495) 917-5774
Moscow
N. O. Postanogova
Perm State Medical University named after academician E.А.Wagner
Russian Federation
Russian Federation
Nina Ol. Postanogova – assistant in Department of Pediatrics with Course of Outpatient Pediatrics
+7 (342) 2127916
L. V. Sofronova
Perm State Medical University named after academician E.А.Wagner
Russian Federation
Russian Federation
Lyudmila V. Sofronova – Dr. Sci. (Med.), professor in Department of Pediatrics with a Course of Outpatient Pediatrics
+7 (342) 2127916
N. A. Kontarov
Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Russian Federation
Nikolay Al. Kontarov – Cand. Sci. (Biol.), leading researcher
+7 (495) 674-01-99
MoscowReferences
1. Tatochenko VK, Ozereckovsky NA, Fedorov AM. Immunoprophylaxis – 2011: Reference book. Moscow: Pediatr; 2018 (In Russ.).
2. Yuminova NV, Kontarova EO, Balaev NV et al. Vaccination of measles, mumps and rubella: tasks, problems and realities. Epidemiology and Vaccinal Prevention. 2011; 4 (59):40–44 (In Russ.).
3. Maple PA. Application of oral fluid assays in support of mumps, rubella and varicella control programs. Vaccines (Basel). 2015; 3 (4): 988–1003.
4. Jin L, Örvell C, Myers R et al. Genomic diversity of mumps virus and global distribution of the 12 genotypes. Rev. Med.Virol. 2015; 25 (2): 85–101.
5. Bodewes R, van Rooijen K, Cremer J et al. Optimizing molecular surveillance of mumps genotype G viruses. Infect. Genet. Evol. 2019; 69: 230–234.
6. Westphal DW, Eastwood A, Levy A et al. A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study. Lancet Infect. Dis. 2019; 19 (2): 177–184.
7. On the state of the sanitary-epidemiological well-being of the population in the Russian Federation in 2018: state report. Available at: http://15.rospotrebnadzor.ru/documents/10156/384533df-1c98-4f8d-b399-9904979be7fd/ (In Russ.).
8. Vaccine MMR-II. Prescribing Information [Internet]. Merck Sharp and Dohme Corp. Available at: https://www.merck.com/product/usa/pi_circulars/m/mmr_ii/mmr_ii_pi.pdf.
9. Dos Santos BA, Ranieri TS, Bercini M et al. An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines. Rev PanamSalud Publica. 2002; 12 (4): 240–6.
10. Shamsutdinova OA. Live attenuated vaccines for immunization. Infection and Immunity. 2017;7(2):107-116. (In Russ.).
11. National immunobiological company has developed a new combination vaccine Vactrivir for the prevention of measles, rubella and mumps. Epidemiology and Vaccinal Prevention. 2017; 16 (1): 75 (In Russ.).
12. On the state of sanitary and epidemiological welfare of the population in the Perm Territory in 2018: state report. Available at: http://59.rospotrebnadzor.ru/rss_all/-/asset_publisher/Kq6J/content/id/1568562. Accessed: 26 Sep 2019 (In Russ.).
13. Nozdracheva AV, Semenenko TA, Rusakova EV et al. The state of population immunity to measles, rubella and mumps viruses in the population of Moscow in 2016–2017. Epidemiology and infectious diseases. Actual issues. 2019; 9 (2): 31–38 (In Russ.).
14. Yuminova NV, Kontarov NA, Pogarskaya IV et. al. Parotitis. Clinic, epidemiology and genotypes of the virus. Health of Kyrgyzstan. 2018; 2: 102–104 (In Russ.).
15. Marin M, Marlow M, Moore KL et. al. Recommendation of the advisory committee on immunization practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak. MMWR Morb Mortal Wkly Rep. 2018; 67 (1): 33–38.
16. Nunn A, Masud S, Krajden M et. al. Diagnostic yield of laboratory methods and value of viral genotyping during an outbreak of mumps in a partially vaccinated population in British Columbia, CanadaJ. Clin. Microbiol. 2018; 56 (5). Avaible at: https://www.ncbi.nlm.nih.gov/pubmed/29491021.
17. Mankertz A, Beutel U, Schmidt FJ et al. Laboratory-based investigation of suspected mumps cases submitted to the German National Reference Centre for Measles, Mumps, and Rubella, 2008 to 2013. Int. J. Med. Microbiol. 2015; 305: 619–626.
18. Maillet M, Bouvat E, Robert N et al. Mumps outbreak and laboratory diagnosis. J. Clin.Virol. 2015; 62: 14–19.
19. Clinical recommendations (treatment protocol) for the provision of medical care to children with mumps. Available at: http://niidi.ru/dotAsset/011ddcf1-9b27-4554-8a21-df1af0354db2.pdf (In Russ.).
20. Order of the Ministry of Healthcare of the Russian Federation № 830n of 9 November 2012. «The approval of the standard of specialized medical care for children with mild mumps». Available at: http://www.consultant.ru/document/cons_doc_LAW_141606/2ff7a8c72de3994f30496a0ccbb1ddafdaddf518/. (In Russ.).
21. Order of the Ministry of Healthcare of the Russian Federation №832n of 9 November 2012. « Аpproval of the standard of specialized medical care for children with severe mumps ». Available at: http://www.consultant.ru/document/cons_doc_LAW_145939/2ff7a8c72de3994f30496a0ccbb1ddafdaddf518/. Accessed: 12 Sep 2019. (In Russ.).
22. Patel LN, Arciuolo RJ, Fu J et al. Mumps outbreak among a highly vaccinated university community-new york city, january–april 2014. Clin Infect Dis. 2017; 64 (4): 408–412.
23. L›Huillier AG, Eshaghi A, Racey CS et al. Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada. Virol. J. 2018; 15 (1): 98.
Review
For citations:
Semerikov V.V., Yuminova N.V., Postanogova N.O., Sofronova L.V., Kontarov N.A. Epidemic Mumps in Russia: Epidemic Situation, Key Challenges and Solutions. Epidemiology and Vaccinal Prevention. 2019;18(6):75-80. (In Russ.) https://doi.org/10.31631/2073-3046-2019-18-6-75-80
Views:
2175
Email this article 